In IFN-γ-depleted mice, the anti-tumor response decreased, whereas in NK1.1-depleted mice, the combination therapy exerted the same effect on tumor progression, suggesting that NK cells act as weak effectors against tumor progression in this experiment. Here, IFNG is linked to neoplasm.